A Diagnostic clinical study to evaluate Vyadhi Vipareeta Upashaya in Apathyanimittaja Madhumeha purvarupa, Pre Diabetes

A diagnostic randomized placebo controlled clinical trial to evaluate Vyadhi Vipareeta Upashaya in Apathyanimittaja Madhumeha Purvarupa, Pre-Diabetes - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/062671

Enrollment

Registered

2024-02-15

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R730- Abnormal glucose

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients of age group between 30-50yrs fulfilling diagnostic criteria irrespective of gender, religion, socio-economic status Patients having signs & symptoms of Prameha Purvarupa(Pre-diabetes) Patients having positive results FPG-100 -125 mg/dl, PPG-140-199 mg/dl, HbA1C-5.7-6.4% WHO1 Patients having BMI >25 Patients not on anti-diabetic medications

Exclusion criteria

Exclusion criteria: Patients aged below 30yrs & above 50yrs Type 1DM, Chronic cases of T2DM with known complications (Diabetic Neuropathy, Nephropathy, Retinopathy, Ketoacidosis, wounds) Currently on anti-diabetic medications-insulin Systemic & auto immune diseases- Hypertension, Cardiovascular diseases, Gastro-intestinal disease, Hepatitis, HIV, PCOS Hormonal therapy Pregnant women, lactating mothers

Design outcomes

Primary

Measure	Time frame
To assess changes in the grading of clinical features of Apathyanimittaja Madhumeha Purvarupa, prediabetes, 15DHRQoL index, etiological factors- before and after administration of Vyadhi Vipareeta UpashayaTimepoint: The outcome assessment will be done on day 0, day7, day15, day 30 of the study	—

Secondary

Measure	Time frame
To assess overall well being of the subjects, guidance about lifestyle, diet changesTimepoint: from day 0 the study to day 30 of the follow up period	—

Countries

India

Contacts

Public ContactRaj Agrawal

Rajiv Gandhi University of Health Sciences, Bengalauru, Karnataka

drrashmibv@sdmayurbangalore.in9739566112

Outcome results